Physician profile
Michael S Hirsch
NPI 1912984220
$9,961.83
in general payments reported to CMS, 2019-2025
52 companies · $1,036 in 2025
The $1,036 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,438 · 2020: $1,398 · 2021: $1,942 · 2022: $1,441 · 2023: $1,517 · 2024: $1,189 · 2025: $1,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,742.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,348.18 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $961.57 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $804.27 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $783.43 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Amarin Pharma, INC. | $760.03 | 2019-2023 | |
| Amgen INC. | $708.72 | 2019-2024 | Prolia, Evenity, Repatha |
| Glaxosmithkline, LLC. | $588.73 | 2020-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $503.63 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $286.80 | 2022-2025 | |
| Kyowa Kirin, INC. | $241.50 | 2023-2025 | Crysvita |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.47 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $181.58 | 2019-2024 | Xifaxan |
| Janssen Pharmaceuticals, INC | $179.86 | 2019-2023 | Xarelto |
| Allergan, INC. | $169.82 | 2019-2020 | |
| Radius Health, INC. | $168.05 | 2019-2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $158.93 | 2021-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $152.23 | 2019-2024 | |
| Abbott Laboratories | $142.30 | 2019-2025 | Freestyle Libre |
| Merck Sharp & Dohme LLC | $140.55 | 2019-2023 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Exact Sciences Corporation | $134.17 | 2023-2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $129.38 | 2019-2023 | Seglentis, Livalo |
| Corcept Therapeutics | $127.65 | 2024-2025 | Korlym |
| Teva Pharmaceuticals USA, INC. | $120.29 | 2019-2024 | Austedo Xr |
| Biohaven Pharmaceuticals, INC. | $75.53 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $75.00 | 2019 | |
| Currax Pharmaceuticals LLC | $60.63 | 2021-2025 | Contrave |
| Horizon Therapeutics Plc | $60.11 | 2020-2022 | |
| Seqirus USA INC | $56.24 | 2023-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Sumitomo Pharma America, INC. | $49.27 | 2023 | Gemtesa |
| Sanofi-Aventis U.S. LLC | $48.05 | 2019-2020 | |
| Medicure Pharma INC. | $37.84 | 2019-2025 | Zypitamag |
| Paratek Pharmaceuticals, INC. | $34.20 | 2021-2022 | |
| Dexcom, INC. | $29.80 | 2023-2024 | Dexcom G6 Transmitter |
| Viiv Healthcare Company | $29.64 | 2025 | Apretude |
| Alvogen INC | $29.41 | 2024 | Teriparatide |
| Biohaven Pharmaceutical Holding Company LTD. | $29.26 | 2022 | |
| Globus Medical, INC. | $27.90 | 2025 | Senza |
| Mylan Specialty L.P. | $26.36 | 2021 | |
| Antares Pharma, INC. | $24.45 | 2021 | |
| Idorsia Pharmaceuticals US INC | $24.06 | 2023 | Quviviq |
| Intra-Sana Laboratories | $23.34 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Xeris Pharmaceuticals, INC. | $21.81 | 2024 | Gvoke Hypopen |
| Verity Pharmaceuticals INC. | $21.36 | 2025 | Tlando |
| Arbor Pharmaceuticals, INC. | $19.64 | 2021 | |
| Zyla Life Sciences, INC. | $19.51 | 2019 | |
| Dynavax Technologies Corporation | $19.02 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.77 | 2019 | |
| Ironwood Pharmaceuticals, INC | $16.75 | 2022 | |
| Sanofi Pasteur INC. | $16.04 | 2022 | |
| Ibsa Pharma INC. | $16.00 | 2023 | Tirosint, Licart |
| Hikma Pharmaceuticals USA | $15.00 | 2024 | Ryaltris |
| Lucid Diagnostics INC. | $13.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.